跳至主要内容
临床试验/NCT01311388
NCT01311388Unknown不适用

Construction of the "Patient-Centered"Molecular Pathology Diagnostic Center

Taipei Medical University WanFang Hospital1 个研究点 分布在 1 个国家目标入组 1,500 人开始时间: 2010年8月最近更新:
适应症

试验速览

阶段
不适用
入组人数
1,500
试验地点
1

研究概览

简要总结

The investigators want to achieve the goal of diagnosis in early phase, accurate treatment and existence for a long period in order to screen in early phase, diagnose in clinical trial, choose treatment and evaluate prognosis of cancers by establishing molecular pathology tools.

详细描述

This research is going to discuss the biomarker expression of common malignant neoplasm (tumor)among Taiwanese, such as large intestine rectal cancer, breast cancer, prostate gland cancer, lung cancer, oral cancer, gastric cancer, liver cancer, cervical cancer, cancer of the womb, ovarian cancer, carcinoma of urinary bladder, kidney cancer and so on.

The investigators hope to find the biomarker of common tumors among Taiwanese in order to develop the tools of tumor screening, diagnosis, treatment methods and prediction prognosis

研究设计

研究类型
Observational
时间视角
Retrospective

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • above 20 years old
  • all kinds of cancer patients

排除标准

  • under 20 years old
  • none cancer patients

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验